Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...

Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Breye Therapeutics has announced that danegaptide, a potential oral treatment for nonproliferative diabetic retinopathy, has ...

A diabetic eye screening appointment usually takes about 30 minutes: We’ll ask you to read some letters on a chart. We’ll put drops in your eyes. These may sting for a few seconds and may make your ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Diabetic retinopathy, a type of diabetic eye disease, is one of the leading causes of blindness in the United States. Despite this, almost 40% of people with diabetes don’t get an annual eye exam.

Many people with diabetes have the earliest stage of diabetic retinopathy, called mild nonproliferative diabetic retinopathy (NPDR), without even knowing it, according to the American Academy of ...

The trial subjects were adults with either type 1 or type 2 diabetes, exhibiting central involvement in diabetic macular ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

“The SMART AI application enables ophthalmologists to streamline patient screening, empowers primary care providers to ...

India, often labelled the diabetic capital of the world, faces an alarming crisis with over 77 million people diagnosed with ...

NOX4 is expressed in retinal cells, including vascular cells, affected by diabetic retinopathy. Studies have shown that NOX4 promotes oxidative stress and inflammation in the retina, leading to ...